Print This Page
Share this page: More

Trevena Heart Failure Study

Summary of Trial: A randomized, double-blind, placebo-controlled, adaptive, ascending dose-titration study to evaluate the safety, tolerability, pharmacokinetics, and invasive hemodynamics of TRV120027 in patients with stable  heart failure.

PI: Dr. Stuart Russell

If interested, please call 410-955-5708 or email Dr. Russell at